Eunyoung Choi
-
Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees
Eunyoung Choi and Ken Lau receive funding for novel cancer research, which may ultimately result in cancer detection and treatment options for patients. The fund supports early-stage, high-risk high-reward research projects and honor Cohen’s seminal discoveries, which led to the invention of many anticancer drugs used today. Read MoreNov. 21, 2024
-
Gastric Cancer Foundation funds Eunyoung Choi research
The Gastric Cancer Foundation has awarded a one-year $100,000 research grant to Eunyoung Choi, PhD, assistant professor of Surgery in the Section of Surgical Sciences, to support her efforts to find a way to disrupt the transformation of dysplastic stem cells into stomach cancer. The award was one of… Read MoreNov. 18, 2022
-
Molecular ‘switch’ may illuminate stomach disorders
An international team that included researchers from Vanderbilt University Medical Center has discovered a molecular switch that induces rapid proliferation of zymogen granule-secreting chief cells in the stomach to regenerate damaged tissue. The finding, which was reported earlier this month in the journal Cell Stem Cell, may be crucial… Read MoreMay. 19, 2022